Plain-English translation of NCT06077591 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to treating advanced cancers that have stopped responding to standard chemotherapy or targeted drugs. Doctors will take a small sample of your tumor and use genetic testing and special lab techniques to grow mini-versions of your tumor. They will then test different medications against these mini-tumors to see which ones work best for your specific cancer.
Many patients with advanced cancers find that standard treatments stop working after a while. This trial exists to see if personalized testing of your individual tumor can help doctors find better treatment options tailored just for you, rather than using a one-size-fits-all approach.
You likely qualify if…
You likely don't qualify if…
You will have a small tissue sample taken from your tumor through a biopsy or surgical procedure. Over the next 2–4 weeks, doctors will extract genetic information from your tumor and grow mini-tumors in the lab, then test various medications against them. During this waiting period, you may receive standard treatment as your doctor recommends. Once the testing is complete (usually within 4–6 weeks), a team of doctors will review the results and recommend the medication that showed the best response in your tumor sample. Your oncologist will then decide which treatment to prescribe for you.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Hong Kong